STAR.BO

Healthcare Drug Manufacturers - Specialty & Generic

Strides Pharma Science Limited

₹1,085.85
+2.90 +0.27% today

Price History

Not enough data

Key Stats

Market Cap
100.09B
Avg Volume
21,884
P/E (TTM)
16.32
EPS
₹66.55
52W High
₹1,260.10
52W Low
₹769.60
Div. Yield
0.0%

Analyst Ratings

Buy
0
Str Buy
2
Buy
0
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
11.38
P/B Ratio
3.22
P/S Ratio
2.00
EV/EBITDA
14.12
EV/Revenue
2.31
PEG Ratio
0.10

Margins

Gross Margin 56.2%
Operating Margin 13.7%
Net Margin 12.3%
EBITDA Margin 16.4%

Growth & Returns

Revenue Growth (YoY)
13.0%
Earnings Growth (YoY)
57.4%
Earnings Growth (QoQ)
57.5%

Liquidity & Leverage

Debt / Equity
0.56
Total Cash
2.04B
Total Debt
17.58B

About

Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment. It also provides branded generics, prescription medicines, and over-the-counter products for infectious diseases, pain management, cardiology, and wellness; and prescription generics for anti-infectives, CNS, cardiovascular, gastroenterology, pain management, and specialty products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

www.strides.com